{"filing":{"accession_number":"0001116463-26-000046","cik":"0001116463","ticker":"OSUR","company_name":"ORASURE TECHNOLOGIES INC","form":"8-K","filing_date":"2026-06-11","report_date":null,"primary_document":"osur-20260611.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1116463/000111646326000046/osur-20260611.htm"},"events":[{"id":5313,"run_id":4656,"accession_number":"0001116463-26-000046","anchor_item_number":"8.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"summary":"OraSure announced FDA clearance of its Colli-Pee™ Dx Urine Collection Kit for use with Roche molecular diagnostic systems to detect four sexually transmitted infections. This is a material regulatory milestone that expands the company's product portfolio and market reach through a partnership with a major diagnostics company (Roche), but does not fit neatly into the more specific event categories (not an earnings release, M\u0026A activity, impairment, or litigation). The disclosure warrants classification as a material product/regulatory event under \"other_material.\"","company_name":"ORASURE TECHNOLOGIES INC","ticker":"OSUR","filing_date":"2026-06-11","form":"8-K","submitted_at":null,"items":[{"id":6136,"accession_number":"0001116463-26-000046","item_number":"8.01","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"OraSure announced FDA clearance of its Colli-Pee™ Dx Urine Collection Kit for use with Roche molecular diagnostic systems to detect four sexually transmitted infections. This is a material regulatory milestone that expands the company's product portfolio and market reach through a partnership with a major diagnostics company (Roche), but does not fit neatly into the more specific event categories (not an earnings release, M\u0026A activity, impairment, or litigation). The disclosure warrants classification as a material product/regulatory event under \"other_material.\"","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T13:03:06.211659+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6136,"accession_number":"0001116463-26-000046","item_number":"8.01","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"OraSure announced FDA clearance of its Colli-Pee™ Dx Urine Collection Kit for use with Roche molecular diagnostic systems to detect four sexually transmitted infections. This is a material regulatory milestone that expands the company's product portfolio and market reach through a partnership with a major diagnostics company (Roche), but does not fit neatly into the more specific event categories (not an earnings release, M\u0026A activity, impairment, or litigation). The disclosure warrants classification as a material product/regulatory event under \"other_material.\"","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T13:03:06.211659+00:00","company_name":"ORASURE TECHNOLOGIES INC","ticker":"OSUR","filing_date":"2026-06-11"}]}